Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.609,58
-0,09%
NASDAQ
17.620,41
0,87%
Bitcoin
83.153,74
5,97%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Atea Pharmaceuticals Inc (AVIR) Atea Pharmaceuticals Inc (AVIR) Notizie

Atea Pharmaceuticals Inc

AVIR
2,855
-0,065 (-2,23%)
Ultimo aggiornamento: 20:12:49
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202522:45EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
24/2/202514:17EDGAR2Form 8-K - Current report
05/2/202500:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202500:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:00GLOBEAtea Pharmaceuticals to Highlight 2025 Strategic Priorities..
08/1/202513:00GLOBEAtea Pharmaceuticals to Present at the 43rd Annual J.P...
16/12/202411:00GLOBEAtea Pharmaceuticals Retains Financial Advisor to Explore..
04/12/202413:00GLOBEAtea Pharmaceuticals Announces Positive Results from Phase 2..
26/11/202413:00GLOBEAtea Pharmaceuticals to Present and Provide a Business..
20/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/11/202417:00GLOBEAtea Pharmaceuticals Presents Multiple New Datasets..
07/11/202422:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:27EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2024 Financial..
31/10/202412:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2024 Financial..
30/10/202412:00GLOBEAtea Pharmaceuticals to Present New Data Supporting the..
19/9/202422:22EDGAR2Form 144 - Report of proposed sale of securities
18/9/202422:09EDGAR2Form 144 - Report of proposed sale of securities
17/9/202422:16EDGAR2Form 144 - Report of proposed sale of securities
13/9/202413:00GLOBEAtea Pharmaceuticals Provides Update on Global Phase 3..
28/8/202413:00GLOBEAtea Pharmaceuticals Announces Publication of Additional..
07/8/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:15EDGAR2Form 8-K - Current report
07/8/202422:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2024 Financial..
31/7/202413:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2024 Financial..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:04EDGAR2Form 144 - Report of proposed sale of securities
05/6/202413:00GLOBEAtea Pharmaceuticals Presents Positive Initial Phase 2 Data..
04/6/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202413:00GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
22/5/202413:00GLOBEAtea Pharmaceuticals Presents New Data Showcasing Potential..
14/5/202422:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:16EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEAtea Pharmaceuticals Reports First Quarter 2024 Financial..
07/5/202413:00GLOBEAtea Pharmaceuticals to Host First Quarter 2024 Financial..
29/4/202413:00GLOBEAtea Announces Presentation of Data Highlighting Favorable..
27/3/202412:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
Apertura: 2,885 Min: 2,82 Max: 2,91
Chiusura: 2,92

La tua Cronologia

NASDAQ
AVIR
Atea Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci